Next Article in Journal
Simvastatin Reduces Protection and Intestinal T Cell Responses Induced by a Norovirus P Particle Vaccine in Gnotobiotic Pigs
Next Article in Special Issue
Pulmonary Findings of [18F]FDG PET/CT Images on Asymptomatic COVID-19 Patients
Previous Article in Journal
Use of Rv0222-Rv2657c-Rv1509 Fusion Protein to Improve the Accuracy of an Antibody ELISA for Extra-Pulmonary Tuberculosis in Humans
Previous Article in Special Issue
Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Emerging and Re-Emerging Diseases

by
Wen-Hung Wang
1,2,
Arunee Thitithanyanont
3,
Aspiro Nayim Urbina
1 and
Sheng-Fan Wang
1,4,5,*
1
Center for Tropical Medicine and Infectious Disease, Kaohsiung Medical University, Kaohsiung 80708, Taiwan
2
Division of Infectious Disease, Department of Internal Medicine, Kaohsiung Medical, University Hospital, Kaohsiung Medical University, Kaohsiung 80708, Taiwan
3
Department of Microbiology, Faculty of Science, Mahidol University, Bangkok 10400, Thailand
4
Department of Medical Laboratory Science and Biotechnology, Kaohsiung Medical University, Kaohsiung 80708, Taiwan
5
Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80708, Taiwan
*
Author to whom correspondence should be addressed.
Pathogens 2021, 10(7), 827; https://doi.org/10.3390/pathogens10070827
Submission received: 22 June 2021 / Revised: 26 June 2021 / Accepted: 29 June 2021 / Published: 30 June 2021
(This article belongs to the Collection Emerging and Re-emerging Pathogens)
Throughout history, infectious diseases have vastly impacted human civilization. Around fifty years ago, many people believed that the age-old battle of humans against infectious disease was virtually over and that humankind were the winners [1,2]. Unfortunately, several new diseases emerged during the past decades (such as AIDS, West Nile fever, and Legionnaires’ disease) [2,3]. In addition, certain traditional diseases resurged with full effects (such as malaria, Lyme disease, and tuberculosis) [3]. Globally, infectious diseases remain the leading cause of death, therefore it is clear that humans are yet to be declared the winners in this battle against infectious diseases.
Infectious diseases have continuously affected human health and there has been a relentless appearance of various infectious disease outbreaks reported, including the plague that scourged Europe during the Middle Ages [4], yellow fever that demolished Napoleon’s forces in Haiti during the early nineteenth century [5], and the influenza that caused a pandemic with the highest fatality (around 50 million deaths) in 1918 [6,7]. In the twentieth century, by increasing public health knowledge and interventions, the burden of infectious diseases was reduced, particularly in more developed countries [8]. Furthermore, the later industrialization and urbanization brought great improvements in sanitation, house structural development (such as windows screened with netting), and vector control. These measures collectively ameliorated the transmission rates by reducing contact with particular infectious agents [8,9]. In addition, the discovery of penicillin in 1928, as well as the development of various vaccines, ushered the era of treatment and prevention in public health, significantly contributing to the eradication of certain infectious diseases [10].
After World War II, several health organizations were established, including the US Centers for Disease Control (CDC) and the World Health Organization (WHO) that led multiple campaigns to completely eradicate specific infectious diseases, such as smallpox, a highly infectious viral disease that was completely eradicated by 1980 via vaccination campaigns [11]. These campaigns and actions established optimism and confidence to combat and control various infectious diseases worldwide.
These infectious diseases mentioned above have been identified as emerging infectious diseases (EIDs) and re-emerging infectious diseases (REIDs) [12]. EIDs are diseases that have not occurred in humans before; have occurred previously but affected only small numbers of people in isolated places; or have occurred throughout human history but have only recently been recognized as distinct diseases or as a result of a new mutant strains [12]. According to US CDC, the EIDs are defined as diseases whose incidence numbers in humans have increased in the past two decades, causing public health problems either locally or internationally [13]. REIDs are defined as diseases that were once major health problems and then declined dramatically but are recently reoccurring, leading to major health complications [13]. Although most control and prevention efforts have been implemented, both EIDs and REIDs are still onset intermittently and pose threats and burdens to human health. Some recent human EIDs and REIDs are shown in Table 1.
The occurrence of EIDs and REIDs are influenced by a variety of factors, including human behavior, microbial adaptation, ecology, globalization, and public health infrastructure [14]. In addition, most of these factors could be associated with the increasing number of human populations, overcrowding in cities with poor sanitation, fast and intense international traveling, changes in the handling or processing of food, and increased exposure of humans to microbial carrying vectors and reservoirs in nature [15]. In the fourteenth century, the first protective legislation was implemented which evolved over the centuries into the current International Health Regulations [16,17]. The first recorded quarantine regulations were reported in Venice in 1377, which was imposed to protect against diseases carried by ship borne rats [18,19]. Almost five centuries later, the first International Sanitary Conference was held which laid down certain principles for protection against disease, until 1951 when the International Sanitary Regulations was established, providing a framework on quarantine measures [20].
Furthermore, as one of the major factors, travel has always been a channel to the spreading of disease across the world. Therefore, when there are incidences of EIDs or REIDs, most countries will tighten their borders, restricting immigration and initiating strict surveillance on the products confiscated at airports and ports from travelers. For example, COVID-19, an EID, has disseminated from the first reported city (Wuhan, China) to many countries worldwide via global traveling and immigration [21,22,23]. In addition, the African swine fever (ASF), a highly contagious hemorrhagic viral disease associated with high fatality rates in domestic and wild pigs, recently caused outbreaks near the borders of China and has a remarkable capacity for transboundary and transcontinental spread potential, subsequently posing a threat to neighboring countries of China [24,25,26].
Unfortunately, certain pathogens or microorganisms related to EIDs or REIDs are being used as bioweapons to cause the threat of bioterrorism via release of such viruses, bacteria, or other agents leading to additional complexities in how EIDs or REIDs affect global health [27,28]. A number of recent bioterrorism events have had a dramatic impact on public health policies and resource allocations. Some bioterrorism agents used to cause attacks include anthrax, smallpox, melioidosis, and glanders [27]. Although advanced research and technology have provided better diagnostic capabilities as well as basic general knowledge to dissect the various factors and determinants regarding pathogenesis, virulence, cytotoxicity, and micro-host interaction, much of them still remain unknown or not yet fully understood, mandating the necessity of more efforts to address these pathogenic factors and finetune mechanisms [29].
Regarding the transmission route, several EIDs have resulted from animal-to-human transmission. The transmission of a pathogen between animals and humans is known as zoonotic transmission or zoonosis [30]. Zoonosis is currently recognized as one of the most vital pathways for the emergence of new infectious disease to humans. Reports indicated that an estimated 75% of all known EIDs originate from some type of animal reservoir [31,32]. Some examples of zoonotic disease include HIV/AIDS, SARS, MERS, several hemorrhagic fevers, Lyme disease, plague, and avian or swine origin influenza [32,33,34,35,36,37]. Each of these diseases possesses a unique etiology and a direct or indirect transmission route. Humans have a high chance to become infected due to their close contact with asymptomatic or sick animals carrying the new pathogen. Additionally, effective control of zoonotic diseases is particularly difficult, since recognizing an emerging zoonotic disease often does not occur until a major outbreak is already ongoing [31]. If the responsible zoonotic pathogen is highly transmissible, then future epidemic spread will occur even after recognition. As previously mentioned, population growth has had a drastic impact on human health. Greater zoonotic disease potential can result from this growth primarily due to an increased interaction between humans and animal habitats [38].
Several reports indicate that ecology or etiology of EIDs or REIDs are very complex, requiring a sophisticated, interdisciplinary response to reduce disease impact. One strategy to address these complexities has been coined ‘One Health’ [39,40]. One Health is an approach for designing and implementing programs, policies, legislation, and research in which multiple sectors communicate and work together to achieve better public health outcomes. One Health is also a moniker for the interdisciplinary strategy, bringing together human, animal, and environmental health professionals to address complex global health problems [41]. Overall, One Health is an important approach to improve the effectiveness of public health response and interventions as well as recruitment and application of multiple areas of expertise to work together to fight against EIDs or REIDs.

Author Contributions

W.-H.W. and A.N.U. analyzed the data and drafted the manuscript. A.T. and S.-F.W. discussed the concept and designed the manuscript. S.-F.W. made critical revisions and gave suggestions of the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by grants from the Ministry of Science and Technology, R.O.C. (MOST 108-2320-B-037-035-MY3, MOST 109-2823-8-037-002-CV & MOST 110-2918-I-037-002) and Kaohsiung Medical University Research Center Grant (KMU-TC109B02).

Acknowledgments

The authors wish to thank the staff from Center for Tropical Medicine and Infectious Disease and Kaohsiung Medical University.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Cunha, B.A. Historical aspects of infectious diseases, part I. Infect. Dis. Clin. N. Am. 2004, 18, 11–15. [Google Scholar] [CrossRef]
  2. Mukherjee, S. Emerging infectious diseases: Epidemiological perspective. Indian J. Dermatol. 2017, 62, 459–467. [Google Scholar] [CrossRef]
  3. McFee, R.B. Emerging infectious diseases overview. Dis. Mon. 2018, 64, 163–169. [Google Scholar] [CrossRef] [PubMed]
  4. Zietz, B.P.; Dunkelberg, H. The history of the plague and the research on the causative agent Yersinia pestis. Int. J. Hyg. Environ. Health 2004, 207, 165–178. [Google Scholar] [CrossRef] [PubMed]
  5. Patterson, K. Yellow fever epidemics and mortality in the United States, 1693–1905. Soc. Sci. Med. 1992, 34, 855–865. [Google Scholar] [CrossRef]
  6. Yen, H.-L.; Webster, R.G. Pandemic influenza as a current threat. Curr. Top. Microbiol. Immunol. 2009, 333, 3–24. [Google Scholar] [CrossRef]
  7. Zumla, A.; Hui, D.S. Emerging and reemerging infectious diseases: Global overview. Infect. Dis. Clin. N. Am. 2019, 33. [Google Scholar] [CrossRef]
  8. Armstrong, G.L.; Conn, L.A.; Pinner, R.W. Trends in infectious disease mortality in the United States during the 20th century. JAMA 1999, 281, 61–66. [Google Scholar] [CrossRef] [Green Version]
  9. Neiderud, C.-J. How urbanization affects the epidemiology of emerging infectious diseases. Infect. Ecol. Epidemiol. 2015, 5, 27060. [Google Scholar] [CrossRef]
  10. Clardy, J.; Fischbach, M.; Currie, C.R. The natural history of antibiotics. Curr. Biol. 2009, 19, R437–R441. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  11. Melamed, S.; Israely, T.; Paran, N. Challenges and achievements in prevention and treatment of smallpox. Vaccines 2018, 6, 8. [Google Scholar] [CrossRef] [Green Version]
  12. Tabish, S.A. Recent trends in emerging infectious diseases. Int. J. Health Sci. 2009, 3, 5–8. [Google Scholar]
  13. US. CDC. Emerging Infectious Diseases. 2018. Available online: https://www.cdc.gov/niosh/topics/emerginfectdiseases/default.html (accessed on 27 June 2021).
  14. Smolinski, M.S.; Hamburg, M.A.; Lederberg, J. (Eds.) Microbial Threats to Health: Emergence, Detection, and Response. In Microbial Threats to Health: Emergence, Detection, and Response; National Academic Press: Washington, DC, USA, 2003. [Google Scholar]
  15. Lindahl, J.F.; Grace, D. The consequences of human actions on risks for infectious diseases: A review. Infect. Ecol. Epidemiol. 2015, 5, 30048. [Google Scholar] [CrossRef] [Green Version]
  16. Bansal, R.D.; Bhasin, S.K. New, emerging and re-emerging infectious diseases. Indian J. Public Health 1997, 41, 35. [Google Scholar]
  17. Longbottom, H. Emerging infectious diseases. Commun. Dis. Intell. 1997, 21, 89–93. [Google Scholar]
  18. Ziskind, B.; Halioua, B. The history of quarantine. Rev Prat 2008, 58, 2314–2317. [Google Scholar]
  19. Felkai, P. History of quarantine II. Orv. Hetil. 2021, 162, 474–478. [Google Scholar] [CrossRef]
  20. Howard-Jones, N. The scientific background of the International Sanitary Conferences, 1851–1938. 2. WHO Chron. 1974, 28, 229–247. [Google Scholar] [PubMed]
  21. Lin, C.Y.; Wang, W.H.; Urbina, A.N.; Tseng, S.P.; Lu, P.L.; Chen, Y.H.; Yu, M.L.; Wang, S.F. Importation of SARS-CoV-2 infection leads to major COVID-19 epidemic in Taiwan. Int. J. Infect. Dis. 2020, 97, 240–244. [Google Scholar] [CrossRef] [PubMed]
  22. Huang, S.W.; Wang, S.F. SARS-CoV-2 entry related viral and host genetic variations: Implications on COVID-19 severity, immune escape, and infectivity. Int. J. Mol. Sci. 2021, 22, 3060. [Google Scholar] [CrossRef] [PubMed]
  23. Huang, S.W.; Miller, S.O.; Yen, C.H.; Wang, S.F. Impact of genetic variability in ACE2 expression on the evolutionary dynamics of SARS-CoV-2 spike D614G mutation. Genes 2020, 12, 16. [Google Scholar] [CrossRef] [PubMed]
  24. Wang, W.-H.; Lin, C.-Y.; Ishcol, M.R.C.; Urbina, A.N.; Assavalapsakul, W.; Thitithanyanont, A.; Lu, P.-L.; Chen, Y.-H.; Wang, S.-F. Detection of African swine fever virus in pork products brought to Taiwan by travellers. Emerg. Microbes Infect. 2019, 8, 1000–1002. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Sánchez-Cordón, P.J.; Montoya, M.; Reis, A.L.; Dixon, L.K. African swine fever: A re-emerging viral disease threatening the global pig industry. Vet. J. 2018, 233, 41–48. [Google Scholar] [CrossRef] [PubMed]
  26. Wang, S.-F.; Wang, W.-H.; Ishcol, M.R.C.; Lin, C.-Y. African swine fever: An emerging threat to Asian countries. J. Exp. Clin. Microbiol. 2019, 2, 14–15. [Google Scholar]
  27. Grafstein, E.; Innes, G. Bioterrorism: An emerging threat. CJEM 1999, 1, 205–209. [Google Scholar] [CrossRef] [Green Version]
  28. Hamburg, A.M. Bioterrorism: Responding to an emerging threat. Trends Biotechnol. 2002, 20, 296–298. [Google Scholar] [CrossRef]
  29. Upadhyay, M.K.; Maroof, K.A. Understanding the emerging and reemerging terminologies amid the COVID-19 pandemic. J. Fam. Med. Prim. Care 2020, 9, 5881–5887. [Google Scholar] [CrossRef] [PubMed]
  30. Richt, J.A.; Feldmann, H. Emerging zoonoses: Recent advances and future challenges. Zoonoses Public Health 2009, 56, 257. [Google Scholar] [CrossRef] [PubMed]
  31. WHO. Zoonotic Disease: Emerging Public Health Threats in the Region 2021. Available online: http://www.emro.who.int/about-who/rc61/zoonotic-diseases.html (accessed on 27 June 2021).
  32. Recht, J.; Schuenemann, V.J.; Sánchez-Villagra, M.R. Host diversity and origin of zoonoses: The ancient and the new. Animals 2020, 10, 1672. [Google Scholar] [CrossRef]
  33. Kongsomros, S.; Manopwisedjaroen, S.; Chaopreecha, J.; Wang, S.-F.; Borwornpinyo, S.; Thitithanyanont, A. Rapid and efficient cell-to-cell transmission of avian influenza H5N1 virus in MDCK cells is achieved by trogocytosis. Pathogens 2021, 10, 483. [Google Scholar] [CrossRef]
  34. Yang, Z.-S.; Huang, S.-W.; Wang, W.-H.; Lin, C.-Y.; Wang, C.-F.; Urbina, A.N.; Thitithanyanont, A.; Tseng, S.-P.; Lu, P.-L.; Chen, Y.-H.; et al. Identification of important N-linked glycosylation sites in the hemagglutinin protein and their functional impact on DC-SIGN mediated avian influenza H5N1 infection. Int. J. Mol. Sci. 2021, 22, 743. [Google Scholar] [CrossRef]
  35. Huang, S.-W.; Wang, S.-F. The effects of genetic variation on H7N9 avian influenza virus pathogenicity. Viruses 2020, 12, 1220. [Google Scholar] [CrossRef]
  36. Wang, W.-H.; Erazo, E.M.; Ishcol, M.R.C.; Lin, C.-Y.; Assavalapsakul, W.; Thitithanyanont, A.; Wang, S.-F. Virus-induced pathogenesis, vaccine development, and diagnosis of novel H7N9 avian influenza A virus in humans: A systemic literature review. J. Int. Med. Res. 2019, 48, 300060519845488. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Wang, S.-F.; Tseng, S.-P.; Loh, E.-W.; Wang, W.-H.; Li, M.-C.; Chen, K.-H.; Tsai, W.-C.; Lee, Y.-M.; Chen, H.-Y.; Liu, F.-T.; et al. Generation and characterization of new monoclonal antibodies against swine origin 2009 influenza A (H1N1) virus and evaluation of their prophylactic and therapeutic efficacy in a mouse model. Dev. Comp. Immunol. 2017, 67, 8–17. [Google Scholar] [CrossRef] [PubMed]
  38. Wu, T.; Perrings, C.; Kinzig, A.; Collins, J.P.; Minteer, B.A.; Daszak, P. Economic growth, urbanization, globalization, and the risks of emerging infectious diseases in China: A review. Ambio 2017, 46, 18–29. [Google Scholar] [CrossRef]
  39. Bhatia, R. Implementation framework for one health approach. Indian J. Med. Res. 2019, 149, 329–331. [Google Scholar] [CrossRef]
  40. MacKenzie, J.S.; Jeggo, M. The One health approach—Why is it so important? Trop. Med. Infect. Dis. 2019, 4, 88. [Google Scholar] [CrossRef] [Green Version]
  41. Ahmed, N.; Ahmed, S.; Sami, A.S. Adverse health events after natural disasters and the ‘One Health’ approach: Animals as vectors for human disease. Infect. Dis. Health 2019, 24, 177–178. [Google Scholar] [CrossRef] [PubMed]
Table 1. Examples of recent human emerging or re-emerging infectious disease.
Table 1. Examples of recent human emerging or re-emerging infectious disease.
Infectious DiseasePathogenEmerging/ReemergingPrimary Transmission
Virus
West Nile feverWest Nile virusReemergingVector-borne
Hantavirus pulmonary syndromeHantavirusEmergingZoonotic
Dengue feverDengue virusReemergingVector-borne
Zika virus diseaseZika virusReemergingVector-borne
Yellow feverYellow fever virusReemergingVector-borne
Japanese encephalitisJapanese encephalitis virusReemergingVector-borne
Marburg hemorrhagic feverMarburg virusReemergingZoonotic
Rift Valley feverRift Valley fever virusReemergingVector-borne
Ebola hemorrhagic feverEbola virusReemergingZoonotic
Lassa feverLassa virusReemergingZoonotic
Hendra virus infectionHendra virusEmergingZoonotic
Nipah virus infectionNipah virusEmergingZoonotic
Highly pathogenic avian influenzaH5N1, H7N9 influenza virus EmergingZoonotic
Severe acute respiratory syndromeSARS-CoV-1EmergingRespiratory (person-to-person)
Middle East Respiratory SyndromeMERS-CoVEmergingZoonotic
COVID-19SARS-CoV-2EmergingRespiratory (person-to-person)
2009 Pandemic influenzaSwine-origin H1N1 influenza virusEmergingRespiratory (person-to-person)
Bacteria
Lyme diseaseBorrelia spp. EmergingVector-borne
CholeraVibrio choleraeReemergingWaterborne
PlagueYersinia pestisReemergingVector-borne
BartonellosisBartonella spp. EmergingZoonotic
Vancomycin-resistant Staphylococcus aureus infectionsStaphylococcus aureusReemergingPerson-to-person
Pathogenic Escherichia coli infectionsPathogenic E. coli strains
(O157:H7 & O104:H4)
EmergingFoodborne
DiphtheriaCorynebacterium diphtheriaeReemergingRespiratory (person-to-person)
Typhoid feverSalmonella typhiReemergingFoodborne, waterborne
Multidrug-resistant tuberculosis infectionsMycobacterium tuberculosisReemergingRespiratory (person-to-person)
Fungal
Cryptococcus gattii infectionsCryptococcus gattiiEmergingEnvironmental exposure
Parasite
Cyclosporiasis infectionsCyclospora cayetanensisEmergingFoodborne, waterborne
Drug-resistant malariaPlasmodium spp. ReemergingVector-borne
Protein
Variant Creutzfeldt–Jakob diseasePrionEmergingZoonotic, foodborne
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Wang, W.-H.; Thitithanyanont, A.; Urbina, A.N.; Wang, S.-F. Emerging and Re-Emerging Diseases. Pathogens 2021, 10, 827. https://doi.org/10.3390/pathogens10070827

AMA Style

Wang W-H, Thitithanyanont A, Urbina AN, Wang S-F. Emerging and Re-Emerging Diseases. Pathogens. 2021; 10(7):827. https://doi.org/10.3390/pathogens10070827

Chicago/Turabian Style

Wang, Wen-Hung, Arunee Thitithanyanont, Aspiro Nayim Urbina, and Sheng-Fan Wang. 2021. "Emerging and Re-Emerging Diseases" Pathogens 10, no. 7: 827. https://doi.org/10.3390/pathogens10070827

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop